texas oncology more breakthroughs. more victories

News Articles

Search Media Coverage
Cancer Center
Cancer Type
Media Type
Year

Spending Time in the Great Outdoors When You Have Cancer

Publication: Jewish Outlook
09/01/2023

Studies have shown being outside can benefit one’s health and well-being, offering opportunities for physical activity while reducing stress and improving mental health. To help patients make the most of the great outdoors, Texas Oncology shares easy, low-impact activities that are suitable for cancer patients and tips for sun safety.

Women + Cancer

Publication: D Magazine
09/01/2023
Anju Nair, M.D., Texas Oncology–Medical City Dallas Building C, discussed how early detection of all types of cancer is a matter of relaying concerning symptoms to a primary doctor and following up closely, noting that breast cancer is often top of mind for women, but it is also important for women to know the signs and symptoms of other cancers that commonly affect women, like colorectal, lung, cervical, skin, and ovarian cancers in women.

Breast Cancer Surgery: What Are My Options?

Publication: Harrison Magazine
09/01/2023

Surgery for breast cancer depends on several factors including the size and location of the tumor, stage of cancer, treatment options, and individual goals and preferences, all of which can have a profound impact on the treatment decisions a woman makes – especially in cases where breast surgery may play a pivotal role in their overall treatment plan. Common surgical procedures used to treat breast cancer include breast-conserving surgery and mastectomy; additional procedures include sentinel lymph node biopsy, lymph node dissection, and breast reconstruction surgery, which can be part of treatment after breast-conserving surgery or mastectomy.

Proton Therapy Benefits Prostate Cancer Treatment

Publication: Texas Monthly
09/01/2023

If prostate cancer is detected early and before the cancer spreads, patients have a nearly 100% chance of survival after five years. Proton therapy delivers extremely precise, high doses of radiation directly to tumors, working to eliminate cancer cells while minimizing exposure to non-targeted, healthy tissue. This precision benefits patients that require treatment to the prostate gland only or to larger target volumes such as those involving lymph nodes.

Is The Drug Elahere An Option When My Ovarian Cancer Returns?

Publication: SurvivorNet
08/21/2023
Noelle G. Cloven, M.D., Texas Oncology–Fort Worth Cancer Center was featured in a video on SurvivorNet discussing the ovarian cancer landscape. Dr. Cloven joined SurvivorNet and dove into the evolving ovarian cancer treatment space discussing topics from the latest guidance on PARP inhibitors, how the new drug Elahere is providing hope to cancer patients, folate receptor⁠–⁠alpha positive ovarian cancer, mirvetuximab soravtansine and more.

Managing An Ovarian Cancer Recurrence: How The New Drug Elahere Is Providing Hope

Publication: SurvivorNet
08/01/2023
Helen Dinkelspiel Eshed, M.D., Texas Oncology-Austin Central and South Austin was featured in various videos on SurvivorNet discussing the ovarian cancer landscape. Dr. Eshed joined SurvivorNet and dove into the evolving ovarian cancer treatment space discussing topics from the latest guidance on PARP inhibitors, how the new drug Elahere is providing hope to cancer patients, folate receptor⁠–⁠alpha positive ovarian cancer, mirvetuximab soravtansine and more.

Niraparib Maintenance Improves Survival in BRCA Wild-Type Ovarian Cancer

Publication: Targeted Oncology
08/01/2023
Robert L. Coleman, M.D., FACOG, FACS, Texas Oncology-The Woodlands spoke with Targeted Oncology about the NOVA trial, how it improves survival in BRCA wild-type ovarian cancer and the real-world findings from this trial, which evaluated second-line maintenance niraparib in patients with recurrent ovarian cancer.

The Four C’s for Balancing Cancer Treatment and the Classroom

Publication: Austin Medical Times, Houston Medical Times, Palestine Herald-Press, Pittsburg Gazette
08/01/2023

Heading back to school with all of the stresses that come with managing a cancer diagnosis is a daunting challenge. No matter if you’re a student or parental guardian of someone in school, learn how proper planning and support can help make it possible to create the right balance between successfully continuing one’s studies and undergoing cancer treatment.

Maintenance Therapy With Niraparib Prolongs PFS in Ovarian Cancer

Publication: Targeted Oncology
07/27/2023
Robert L. Coleman, M.D., FACOG, FACS, Texas Oncology-The Woodlands spoke with Targeted Oncology about the effect of maintenance therapy with niraparib on ovarian cancer. In the article, Dr. Coleman discusses the research he presented at ASCO, which found that niraparib (Zejula) as a maintenance therapy improved progression-free survival (PFS) in patients with newly diagnosed advanced ovarian cancer after first-line platinum-based chemotherapy, regardless of postoperative residual disease or biomarker status.

Texas Oncology Opens New, Expanded Comprehensive Cancer Center in Amarillo

Publication: Medical Construction & Design
07/19/2023

Texas Oncology has opened a new 50,000-square-foot cancer center in Amarillo, expanding the capacity of the practice to meet the growing need for cancer care in the Texas Panhandle region. The general design scheme was inspired by Amarillo’s unique landscape, and materials were selected for their visible texture and linearity to evoke the layers and strata visible in nearby Palo Duro Canyon.